This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations in Fibrosis Detection by Derek Dirocco
Introduction
Derek Dirocco is an innovative inventor based in Brookline, MA (US). He has made significant contributions to the field of medical research, particularly in the detection and treatment of tissue fibrosis. His work focuses on the use of specific markers to diagnose early stages of fibrosis, which is crucial for preventing organ failure.
Latest Patents
Dirocco holds a patent titled "Uses of GLI1 in detecting tissue fibrosis." This patent outlines methods for using Gli-1 as a specific marker for myofibroblast progenitor cells. This innovation allows for the diagnosis of early stages of fibrosis before the onset of organ failure. Additionally, the patent provides methods for isolating Gli-1+ cells, which can be utilized in high-throughput screening of compounds aimed at treating or preventing fibrosis. Furthermore, the patent discusses methods for treating or preventing fibrosis, such as kidney fibrosis, by administering a Gli inhibitor, particularly a Gli-2 inhibitor or a Gli-1/Gli-2 inhibitor.
Career Highlights
Dirocco is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance his research. His work has the potential to significantly impact the medical community by providing new avenues for early diagnosis and treatment of fibrosis.
Collaborations
Dirocco collaborates with notable colleagues, including Rafael Kramann and Benjamin D Humphreys. These partnerships enhance the research efforts and contribute to the development of innovative solutions in the field of fibrosis.
Conclusion
Derek Dirocco's contributions to the detection and treatment of tissue fibrosis represent a significant advancement in medical research. His innovative approaches and collaborations are paving the way for improved patient outcomes in the future.